News | Magnetic Resonance Imaging (MRI) | July 05, 2018

High-Strength MRI May Release Mercury from Amalgam Dental Fillings

While new research suggests ultra-high-field 7T MRI could pose problems for people with amalgam fillings, conventional 1.5T scans were found to be safe

High-Strength MRI May Release Mercury from Amalgam Dental Fillings

July 5, 2018 — Exposure to ultra-high-strength magnetic resonance imaging (MRI) may release toxic mercury from amalgam fillings in teeth, according to a new study appearing online in the journal Radiology. The effect was not seen, however, in the lower strength, more commonly used 1.5-Tesla (T) MRI.

Amalgam fillings, also known as silver fillings, have been a staple of dentistry for many years. Amalgam consists of approximately 50 percent mercury, a known toxin that can cause a host of harmful effects in humans. Despite the presence of mercury, the U.S. Food and Drug Administration (FDA) considers amalgam fillings safe for adults and children older than age six.

“In a completely hardened amalgam, approximately 48 hours after placing on teeth, mercury becomes attached to the chemical structure, and the surface of the filling is covered with an oxide film layer,” said the study’s lead author, Selmi Yilmaz, Ph.D., a dentist and faculty member at Akdeniz University in Antalya, Turkey. “Therefore, any mercury leakage is minimal.”

Previous research has found that exposure to the magnetic fields of MRI could cause mercury to leak from amalgam fillings. This concern has been heightened by the recent arrival of ultra-high-strength 7T scanners in the clinic. The stronger magnetic field of 7T MRI yields more anatomical detail, but its effects on amalgam dental fillings have not been studied.

To learn more, Yilmaz and colleague, Mehmet Zahit Adişen, Ph.D., evaluated mercury released from dental amalgam after 7T and 1.5T MRI in teeth that had been extracted from patients for clinical indications. While 7T MRI was approved by the FDA in 2017, it has extremely limited availability. The lower-strength 1.5T MRI is widely available and commonly used for patient exams.

The researchers opened two-sided cavities in each tooth and applied amalgam fillings. After nine days, two groups of 20 randomly selected teeth were placed in a solution of artificial saliva immediately followed by 20 minutes of exposure to 1.5T or 7T MRI. A control group of teeth was placed in artificial saliva only.

When the researchers analyzed the artificial saliva, the mercury content in the 7T, 1.5T and control group was 0.67 ± 0.18, 0.17 ± 0.06 and 0.14 ± 0.15 parts per million (ppm), respectively.  At 0.67 ppm, the mercury content in the 7T group was approximately four times the levels found in the 1.5T group and the control group.

“In our study, we found very high values of mercury after ultra-high-field MRI,” Yilmaz said. “This is possibly caused by phase change in amalgam material or by formation of microcircuits, which leads to electrochemical corrosion, induced by the magnetic field.”

An important point of discrimination concerning safety and hazard to human health is the amount of mercury that is absorbed by the vital tissues.

“It is not clear how much of this released mercury is absorbed by the body,” Yilmaz said.

Further studies may be warranted, Yilmaz added, to evaluate the relationship between high-field MRI and release of mercury from dental amalgam. The researchers have three ongoing projects focused on phase and temperature changes of dental amalgam across different magnetic fields.

As no evidence of harmful effects was found in the 1.5T group, patients with amalgam fillings should not be unduly concerned about having an MRI exam.

For more information: www.pubs.rsna.org/journal/radiology

Reference

Yilmaz S., Adisen M.Z. "Ex Vivo Mercury Release from Dental Amalgam after 7.0-T and 1.5-T MRI," Radiology. June 26, 2018. https://doi.org/10.1148/radiol.2018172597

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Mobile App Data Collection Shows Promise for Population Health Surveys
News | Population Health | January 10, 2019
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the Qure.ai tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...